SightfileU.S. market data from official filings
Companies › NNNN
ANBIO BIOTECHNOLOGY (NNNN)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001982708 · EDGAR filings · Updated 2026-07-09
ANBIO BIOTECHNOLOGY (NNNN) has reported institutional ownership of 0.1%, with 8 institutional managers holding positions valued at $1.29M per the latest 13F reporting period.
Institutional ownership
0.1%
Institutional managers
8
Reported 13F value
$1.29M
Latest updates
- 2026-07-09 — F-3ASR filed
- 2026-06-12 — Initial insider ownership filed (Form 3)
- 2026-06-12 — Initial insider ownership filed (Form 3)
- 2026-05-19 — Foreign issuer report (6-K) filed
- 2026-04-27 — Foreign issuer report (6-K) filed
- 2026-04-09 — 20-F/A filed
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, ANBIO BIOTECHNOLOGY has 8 institutional holders and institutional ownership of 0.1%.
Related companies
NUTRIBAND INC (NTRB) · CDT EQUITY INC (CDT) · MILESTONE SCIENTIFIC INC (MLSS) · BiomX Inc (PHGE) · PULSENMORE LTD (PLSM) · Lexaria Bioscience Corp (LEXX)
See full history, cross-references and alerts on SightfileSightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-09.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-09.